Silverfin false false 30/06/2025 01/07/2024 30/06/2025 Professor S Bahn 01/08/2005 06 November 2025 The principal activity of the company during the financial year was research and experimental development in biotechnology. 05524107 2025-06-30 05524107 bus:Director1 2025-06-30 05524107 2024-06-30 05524107 core:CurrentFinancialInstruments 2025-06-30 05524107 core:CurrentFinancialInstruments 2024-06-30 05524107 core:Non-currentFinancialInstruments 2025-06-30 05524107 core:Non-currentFinancialInstruments 2024-06-30 05524107 core:ShareCapital 2025-06-30 05524107 core:ShareCapital 2024-06-30 05524107 core:SharePremium 2025-06-30 05524107 core:SharePremium 2024-06-30 05524107 core:RetainedEarningsAccumulatedLosses 2025-06-30 05524107 core:RetainedEarningsAccumulatedLosses 2024-06-30 05524107 core:PlantMachinery 2024-06-30 05524107 core:OfficeEquipment 2024-06-30 05524107 core:PlantMachinery 2025-06-30 05524107 core:OfficeEquipment 2025-06-30 05524107 bus:OrdinaryShareClass1 2025-06-30 05524107 bus:PreferenceShareClass1 2025-06-30 05524107 2024-07-01 2025-06-30 05524107 bus:FilletedAccounts 2024-07-01 2025-06-30 05524107 bus:SmallEntities 2024-07-01 2025-06-30 05524107 bus:AuditExemptWithAccountantsReport 2024-07-01 2025-06-30 05524107 bus:PrivateLimitedCompanyLtd 2024-07-01 2025-06-30 05524107 bus:Director1 2024-07-01 2025-06-30 05524107 core:PlantMachinery core:TopRangeValue 2024-07-01 2025-06-30 05524107 core:OfficeEquipment core:TopRangeValue 2024-07-01 2025-06-30 05524107 2023-07-01 2024-06-30 05524107 core:PlantMachinery 2024-07-01 2025-06-30 05524107 core:OfficeEquipment 2024-07-01 2025-06-30 05524107 core:CurrentFinancialInstruments 2024-07-01 2025-06-30 05524107 bus:OrdinaryShareClass1 2024-07-01 2025-06-30 05524107 bus:OrdinaryShareClass1 2023-07-01 2024-06-30 05524107 bus:PreferenceShareClass1 2024-07-01 2025-06-30 05524107 bus:PreferenceShareClass1 2023-07-01 2024-06-30 iso4217:GBP xbrli:pure xbrli:shares

Company No: 05524107 (England and Wales)

# PSYNOVA NEUROTECH LIMITED

### Unaudited Financial Statements
For the financial year ended 30 June 2025
Pages for filing with the registrar

PSYNOVA NEUROTECH LIMITED

## Unaudited Financial Statements

For the financial year ended 30 June 2025

Contents

PSYNOVA NEUROTECH LIMITED

## STATEMENT OF FINANCIAL POSITION

As at 30 June 2025
PSYNOVA NEUROTECH LIMITED

## STATEMENT OF FINANCIAL POSITION (continued)

As at 30 June 2025

| Note | 2025 |  | 2024
|  | £ |  | £
Fixed assets |  |  |  |
Tangible assets | 3 | 447 |  | 1,031
|  | 447 |  | 1,031
Current assets |  |  |  |
Debtors |  |  |  |
- due within one year | 4 | 163,232 |  | 16,810
- due after more than one year | 4 | 0 |  | 121,250
Cash at bank and in hand |  | 369,088 |  | 382,651
|  | 532,320 |  | 520,711
Creditors: amounts falling due within one year | 5 | ( 31,393) |  | ( 37,628)
Net current assets |  | 500,927 |  | 483,083
Total assets less current liabilities |  | 501,374 |  | 484,114
Net assets |  | 501,374 |  | 484,114
Capital and reserves |  |  |  |
Called-up share capital | 6 | 7,345 |  | 7,345
Share premium account |  | 4,621,497 |  | 4,621,497
Profit and loss account |  | ( 4,127,468 ) |  | ( 4,144,728 )
Total shareholder's funds |  | 501,374 |  | 484,114

For the financial year ending 30 June 2025 the Company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The member has not required the Company to obtain an audit of its financial statements for the financial year in accordance with section 476;
- The director acknowledges their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements; and
- These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime and a copy of the Statement of Income and Retained Earnings has not been delivered.

The financial statements of Psynova Neurotech Limited (registered number: 05524107) were approved and authorised for issue by the Director on 06 November 2025. They were signed on its behalf by:

Professor S Bahn Director |

PSYNOVA NEUROTECH LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2025
PSYNOVA NEUROTECH LIMITED

## NOTES TO THE FINANCIAL STATEMENTS

For the financial year ended 30 June 2025

##### 1. Accounting policies

The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.

##### General information and basis of accounting

Psynova Neurotech Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is St John's Innovation Centre, Cowley Road, Cambridge, CB4 0WS, United Kingdom.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.

##### Going concern

The director has assessed the Statement of Financial Position and likely future cash flows at the date of approving these financial statements. The director has a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.

##### Foreign currency

Transactions in foreign currencies are recorded at the rate of exchange at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies at the Statement of Financial Position date are reported at the rates of exchange prevailing at that date.
Exchange differences are recognised in the Statement of Income and Retained Earnings in the period in which they arise except for exchange differences arising on gains or losses on non-monetary items which are recognised in the Statement of Comprehensive Income.

##### Turnover

Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
Turnover is recognised when the significant risks and rewards are considered to have been transferred to the customer.

##### Interest income

Interest income is recognised when it is probable that the economic benefits will flow to the Company and the amount of revenue can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.

##### Taxation

Current tax
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Statement of Financial Position date.

##### Tangible fixed assets

Tangible fixed assets are stated at cost (or deemed cost) or valuation less accumulated depreciation and accumulated impairment losses. Cost includes costs directly attributable to making the asset capable of operating as intended. Depreciation is provided on all tangible fixed assets, other than investment properties and freehold land, at rates calculated to write off the cost or valuation, less estimated residual value, of each asset on a straight-line basis over its expected useful life, as follows:

Plant and machinery | 6.7 years straight line
Office equipment | 4 years straight line

Residual value represents the estimated amount which would currently be obtained from disposal of an asset, after deducting estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life.

##### Trade and other debtors

Trade and other debtors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest method less impairment losses for bad and doubtful debts, except where the effect of discounting would be immaterial. In such cases the receivables are stated at cost less impairment losses for bad and doubtful debts.

##### Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in creditors: amounts falling due within one year.

##### Trade and other creditors

Trade and other creditors are initially recognised at fair value and thereafter stated at amortised cost using the effective interest rate method, unless the effect of discounting would be immaterial, in which case they are stated at cost.

##### Financial instruments

Financial assets and financial liabilities are recognised when the Company becomes a party to the contractual provisions of the instrument.
Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the Company after deducting all of its liabilities.
Financial assets and liabilities are only offset in the Balance Sheet when, and only when there exists a legally enforceable right to set off the recognised amounts and the Company intends either to settle on a net basis, or to realise the asset and settle the liability simultaneously.

##### Ordinary share capital

The ordinary share capital of the Company is presented as equity.

#### 2. Employees

| 2025 |  | 2024
| Number |  | Number
Monthly average number of persons employed by the Company during the year, including the director | 1 |  | 1

#### 3. Tangible assets

| Plant and machinery |  | Office equipment |  | Total
| £ |  | £ |  | £
Cost |  |  |  |  |
At 01 July 2024 | 595 |  | 3,424 |  | 4,019
At 30 June 2025 | 595 |  | 3,424 |  | 4,019
Accumulated depreciation |  |  |  |  |
At 01 July 2024 | 445 |  | 2,543 |  | 2,988
Charge for the financial year | 89 |  | 495 |  | 584
At 30 June 2025 | 534 |  | 3,038 |  | 3,572
Net book value |  |  |  |  |
At 30 June 2025 | 61 |  | 386 |  | 447
At 30 June 2024 | 150 |  | 881 |  | 1,031

#### 4. Debtors

| 2025 |  | 2024
| £ |  | £
Debtors: amounts falling due within one year |  |  |
Trade debtors | 39,000 |  | 0
Other debtors | 124,232 |  | 16,810
| 163,232 |  | 16,810
Debtors: amounts falling due after more than one year |  |  |
Other debtors | 0 |  | 121,250

#### 5. Creditors: amounts falling due within one year

| 2025 |  | 2024
| £ |  | £
Bank overdrafts | 212 |  | 0
Trade creditors | 516 |  | 30,635
Amounts owed to director | 331 |  | 331
Accruals | 22,850 |  | 2,952
Taxation and social security | 7,348 |  | 3,427
Other creditors | 136 |  | 283
| 31,393 |  | 37,628

There are no amounts included above in respect of which any security has been given by the small entity.

#### 6. Called-up share capital

| 2025 |  | 2024
| £ |  | £
Allotted, called-up and fully-paid |  |  |
13,096,580 Ordinary shares of £ 0.0001 each | 1,310 |  | 1,310
60,354,111 Preference shares of £ 0.0001 each | 6,035 |  | 6,035
| 7,345 |  | 7,345

#### 7. Related party transactions

Transactions with the entity's director

| 2025 |  | 2024
| £ |  | £
Amount owed to director | 331 |  | 331

The loan is interest free and repayable on demand.

Other related party transactions

| 2025 |  | 2024
| £ |  | £
Loan to a connected person | 123,750 |  | 121,250

Interest has been charged on the loan capital at 2.5% per annum and this loan is repayable on demand.